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Background
MicroRNA (miRNA) is engaged in the regulation of
host immunity during HIV infection and may play an
important role in the disease progression. We sought to
identify a diagnostic/prognostic miRNA signature to
diagnose/predict the outcome of chronic HIV infection.
Methods
The expression levels of 754 known human microRNA
were quantified in whole peripheral blood by TaqMan
low density array for 23 chronically HIV-infected sub-
jects. Significance analyses of miRNA expression profiles
were performed on groups with varied levels of CD4+
T cell counts or viral loads. The identified prognostic
miRNA signature was further validated in a 51 HIV+
patient cohort naïve to ART with following up for
2 years. In addition, we assessed their association with
progression-free rate. For the latter, various prediction
algorithms were computed on the basis of weighted
levels of the miRNAs forming the outcome signature.
Results
Of the 10 differentially expressed miRNAs (p<0.001),
3 were validated to contribute to the predictive value
and thereby used as prognostic signature. Based on dif-
ferent prediction models (binary discrete model and lin-
ear models), the prediction accuracy ranged from
84.31% to 88.24% compared with subsequent 2-year fol-
low-up. When applied all the computed classifiers to
serial time-point samples of seven progressors and five
non-progressors collected during the 2-year follow up,
binary discrete model show a better prediction stability.
Low miR-31, miR-29b, miR-590-5p were associated with
poor progression-free rate, independent of age, gender
and known prognostic factors including viral load and
immune activation.
Conclusion
A unique microRNA signature has been associated with
advance disease and identified as potential prognostic
marker, and provides a new strategy to select patients
who would benefit from earlier ART.
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